Skip to main content

Pairings: Jun 3, 2009

Premium

Strategic Diagnostics announced last week Kevin Bratton has joined the company as vice president of finance and chief financial officer, effective June 1.

Bratton joins SDI from EUSA Pharma where he was senior vice president of business operations. Before that he was senior vice president and CFO of Cytogen before it was acquired by EUSA.


Caris Diagnostics announced last week the appointment of David Loesch as director of oncology, clinical trials, and services.

Loesch has been a practicing medical oncologist for more than 18 years and served as co-chairman of the Breast Cancer Committee of the US Oncology Network.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.